Provention bio announces senior leadership addition

Red bank, n.j. , sept. 19, 2022 /prnewswire/ -- provention bio, inc. (nasdaq: prvb) (the "company"), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced that the company has appointed sarah o'brien as chief people officer.

PRVB Ratings Summary

PRVB Quant Ranking